Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
Article in Chinese | MEDLINE | ID: mdl-37248176

ABSTRACT

Objective: To analyze the levels and distribution characteristics of blood cadmium and urinary cadmium in American adults, to analyze the relationship between blood cadmium and urinary cadmium and pulmonary function dose response, and to explore the effect of this index on the risk of chronic obstructive pulmonary disease. Methods: In March 2022, 3785 patients from 2007 to 2012 in NHANES database were selected as the subjects. Collect demography data such as gender and age, and test data such as lung function, blood cadmium concentration and Urine cadimium concentration. The relationship between blood and urine cadmium levels and lung function and pulmonary function and chronic obstructive pulmonary diease (COPD) was analyzed by Mann-Whitney U test or Kruskal-Wallis H test, multivariate linear regression and restricted cubic spline method. Results: The geometric mean of blood cadmium and urine cadmium in American adults was 0.37 g/L and 0.28 g/L, FEV(1) and FEV(1)/FVC among different cadmium exposure groups was statistically significant, and there was a negative linear dose-response relationship between serum Cd and urine Cd concentrations and FEV(1)/FVC levels (P(overall)<0.001, P(non-linear)=0.152; P(overall)<0.001, P(non-linear)=0.926). Compared with the lowest quartile concentration (Q1), the highest quartile blood cadmium concentration (Q4) (OR=1.934, P(trend)=0.000) and urinary cadmium concentration (OR=1.683, P(trend)=0.000) may increased the risk of chronic obstructive pulmonary disease. Conclusion: There is a negative correlation between blood cadmium, urinary cadmium levels and lung function in American adults, and cadmium may increase the risk of chronic obstructive pulmonary disease.


Subject(s)
Cadmium , Pulmonary Disease, Chronic Obstructive , Adult , Humans , Nutrition Surveys , Lung , Respiratory Function Tests
2.
Br Poult Sci ; 62(3): 320-327, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33263413

ABSTRACT

1. The objectives of the present study were to investigate the complete mitochondrial genome, genetic diversity and maternal origin of Huainan Partridge chicken (HPC).2. One complete mitochondrial genome and 37 complete D-loop regions of HPC were sequenced. Moreover, 400 mitochondrial genome D-loop sequences of Chinese native chicken were downloaded from the National Centre for Biotechnology Information database.3. The complete HPC genome was 16,785 bp in size, including 22 tRNA genes, two rRNA genes, 13 protein-coding genes and one non-coding control region. The haplotype diversity and nucleotide diversity of HPC were 0.964, and 0.00615, respectively. Twenty-three variable sites defining 22 haplotypes were identified, and the 22 haplotypes were distributed into three haplogroups (A, B, and C).4. In conclusion, HPC has a typical vertebrate mitochondrial genome, relatively high haplotype diversity, relatively low nucleotide diversity, and potentially three maternal lineages. HPC showed considerable genetic information exchange with Southwest Chinese chicken populations and had not admixed with European commercial breeds in the course of domestication.


Subject(s)
Genome, Mitochondrial , Animals , Chickens/genetics , DNA, Mitochondrial/genetics , Genetic Variation , Haplotypes , Phylogeny
3.
Mol Biol (Mosk) ; 53(1): 64-73, 2019.
Article in Russian | MEDLINE | ID: mdl-30895953

ABSTRACT

The previously developed technology RNA enhancement (RNAe) is reported to increase specific gene expression at post-transcriptional level via a long noncoding RNA (lncRNA). The mechanism for SINEB2-dependent enhancement of translation remains not well understood. Here we present the result of experiments with the folded states of IncRNA in doubly deionized water obtained by slowcool method. These IncRNA were used in RNA pull-down assay that yielded six IncRNA-binding proteins potentially involved in RNAe. The direct interactions of IncRNA with interleukin enhancer-binding factor 3 (ILF3) and eukaryotic initiation factor 4A-I (eIF4Al) in vivo and in vitro were confirmed in RNA-binding protein affinity experiment and electrophoretic mobility shift assay (EMSA), respectively. These observations could explain RNAe phenomenon through IncRNA-dependent guiding of ILF3 protein, which, in turn, recruits polysomes or the factors for translation initiation, and attracting eIF4Al proteins accelerating the unwinding of the secondary structure at the 5'-end of mRNA during translation initiation. Therefore, the hypothetical mechanism through which IncRNAs may regulate the translation of a specific mRNA is proposed.


Subject(s)
Eukaryotic Initiation Factor-4A/metabolism , Nuclear Factor 90 Proteins/metabolism , RNA, Long Noncoding/genetics , RNA, Messenger/genetics , Animals , Mammals/genetics , Protein Biosynthesis
4.
Int J Oral Maxillofac Surg ; 47(3): 374-378, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29074062

ABSTRACT

The psychiatric profiles of 50 patients diagnosed with burning mouth syndrome (BMS) were compared to those of 50 age- and sex-matched individuals as the control group. The Symptom Checklist-90-Revised (SCL-90-R) questionnaire was used to evaluate the role of psychological factors in the development of BMS. Somatization, obsessive-compulsive, depression, anxiety, hostility, phobic anxiety, psychoticism, global severity index (GSI), positive symptom total (PST), and positive symptom distress index (PSDI) scores were significantly higher in the patients with BMS than in the control group. In a subgroup analysis according to sex, women with BMS had higher T-scores for somatization, obsessive-compulsive, paranoid ideation, GSI, PST, and PSDI than women in the control group. In contrast, only the PSDI score was significantly higher in men with BMS compared to men in the control group. There was a significant difference in the T-scores for somatization, psychoticism, and GSI between the three age subgroups (≤50, 51-65, and ≥66 years). The obsessive-compulsive and PSDI scores were significantly higher in patients with BMS who also had at least one chronic disease than in patients with BMS who had no chronic disease. In conclusion, psychological factors are correlated with BMS.


Subject(s)
Burning Mouth Syndrome/psychology , Aged , Case-Control Studies , Female , Humans , Male , Middle Aged , Risk Factors , Severity of Illness Index , Sex Factors , Surveys and Questionnaires
5.
Poult Sci ; 96(12): 4325-4332, 2017 Dec 01.
Article in English | MEDLINE | ID: mdl-29053872

ABSTRACT

This study was to investigate the effect of resveratrol on intestinal morphology, microfloras, and barrier integrity of broilers subjected to heat stress. Two-hundred-seventy 21-day-old Cobb male broilers were randomly allocated to 3 treatment groups, each of which included 6 replicates with 15 birds per replicate. The 3 treatment groups were as follows: the control group, in which birds were exposed to thermoneutral condition (22 ± 1°C), and the heat stress group and heat stress + resveratrol (400 mg/kg) group, in which birds were exposed to cyclic heat stress (33 ± 1°C for 10 h/d from 0800 to 1800 h and 22 ± 1°C for the remaining time. Compared with birds in the control group, birds in the heat stress group exhibited decreased (P < 0.05) final body weight, average daily gain, average daily feed intake, villus height, villus height to crypt depth ratio, goblet cells numbers, populations of Lactobacillus and Bifidobacterium, and mRNA levels of mucin-2, claudin-1, occludin, zona occludens-1, and E-cadherin, and increased (P < 0.05) crypt depth, serum D-lactic acid and fluorescein isothiocyanate dextran contents and diamine oxidase activity, and populations of Salmonella, Escherichia coli, and Clostridium. Compared with birds in the heat stress group, birds in the heat stress + resveratrol group exhibited decreased (P < 0.05) crypt depth, serum D-lactic acid and fluorescein isothiocyanate dextran contents, and populations of Escherichia coli, and increased (P < 0.05) final body weight, villus height, villus height to crypt depth ratio, goblet cells numbers, populations of Lactobacillus and Bifidobacterium, and mRNA levels of mucin-2, claudin-1, occludin, and E-cadherin. Taken together, these results indicated for the first time that dietary addition of resveratrol was effective in partially ameliorating the adverse effects of heat stress on intestinal barrier function in broilers by restoring the impaired villus-crypt structure, modifying the profiles of intestinal microfloras, and altering the mRNA expression of intestinal tight junctions- and adherence junctions-related genes.


Subject(s)
Chickens/physiology , Gastrointestinal Microbiome/drug effects , Heat Stress Disorders/veterinary , Protective Agents/metabolism , Stilbenes/metabolism , Animals , Avian Proteins/genetics , Avian Proteins/metabolism , Chickens/genetics , Heat Stress Disorders/drug therapy , Heat Stress Disorders/etiology , Intestines/drug effects , Male , Protective Agents/administration & dosage , RNA, Messenger/genetics , RNA, Messenger/metabolism , Random Allocation , Resveratrol , Stilbenes/administration & dosage , Tight Junction Proteins/genetics , Tight Junction Proteins/metabolism
6.
NMR Biomed ; 29(6): 690-701, 2016 06.
Article in English | MEDLINE | ID: mdl-27061076

ABSTRACT

The ability to visualize whole-brain vasculature is important for quantitative in vivo investigation of vascular malfunctions in cerebral small vessel diseases, including cancer, stroke and neurodegeneration. Transverse relaxation-based ΔR2 and ΔR2 * MR angiography (MRA) provides improved vessel-tissue contrast in animal deep brain with the aid of intravascular contrast agents; however, it is susceptible to orientation dependence, air-tissue interface artifacts and vessel size overestimation. Dual-mode MRA acquisition with superparamagnetic iron oxide nanoparticles (SPION) provides a unique opportunity to systematically compare and synergistically combine both longitudinal (R1 ) and transverse (ΔR2 and ΔR2 *) relaxation-based MRA. Through Monte Carlo (MC) simulation and MRA experiments in normal and tumor-bearing animals with intravascular SPION, we show that ultrashort TE (UTE) MRA acquires well-defined vascularization on the brain surface, minimizing air-tissue artifacts, and combined ΔR2 and ΔR2 * MRA simultaneously improves the sensitivity to intracortical penetrating vessels and reduces vessel size overestimation. Consequently, UTE-ΔR2 -ΔR2 * combined MRA complements the shortcomings of individual angiograms and provides a strategy to synergistically merge longitudinal and transverse relaxation effects to generate more robust in vivo whole-brain micro-MRA. Copyright © 2016 John Wiley & Sons, Ltd.


Subject(s)
Brain Neoplasms/diagnostic imaging , Cerebral Angiography/methods , Cerebral Arteries/diagnostic imaging , Dextrans , Magnetic Resonance Angiography/methods , Magnetite Nanoparticles , Neovascularization, Pathologic/diagnostic imaging , Animals , Brain Neoplasms/blood supply , Brain Neoplasms/pathology , Cell Line, Tumor , Cerebrovascular Circulation , Contrast Media , Image Enhancement/methods , Neovascularization, Pathologic/pathology , Rats , Rats, Sprague-Dawley , Reproducibility of Results , Sensitivity and Specificity
8.
J Periodontal Res ; 50(4): 461-7, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25229614

ABSTRACT

BACKGROUND AND OBJECTIVE: The main purpose of this study was to isolate and characterize gingival connective tissue-derived mesenchymal stem cells (GMSCs). The secondary purpose was to present a modified isolation method for the GMSCs. MATERIAL AND METHODS: Collected healthy gingival tissue samples were de-epithelialized and minced into small fragments. The tissues were digested by dispase and collagenase IV for 30 min. The first digested cell suspension was discarded, and then additional digestion was performed to the remaining cells in the same solution for 90 min. The isolated cells from gingiva was incubated in 37°C humidified condition and observed by inverted microscope. Cytoskeletal morphology was evaluated by phalloidin immunofluorescence. Potency of the cells was tested by colony-forming unit fibroblast assay. GMSCs were characterized by osteogenic, adipogenic and chondrogenic differentiation, and flow cytometric, immunofluorescence analysis. RESULTS: GMSCs showed spindle-shaped, fibroblast-like morphology, colony-forming abilities, adherence to plastic and multilineage differentiation (osteogenic, adipogenic, chondrogenic) potency. GMSCs expressed CD44, CD73, CD90 and CD105, but did not express CD14, CD45, CD34 and CD19 in flow cytometry. Expression of stem cell markers (SSEA-4, STRO-1, CD146, CD166 and CD271) and a mesenchymal marker (vimentin) were observed by immunofluorescence. CONCLUSIONS: In conclusion, we isolated and characterized stem cells from human gingival connective tissue with modified protocol. GMSCs showed multipotency with high proliferation and characteristics of mesenchymal stem cells. GMSCs are promising sources for tissue engineering and may be obtained during routine procedures under local anesthesia. Further research is needed to evaluate the potential of GSMCs' proliferation and cryopreservation.


Subject(s)
Cell Separation/methods , Gingiva/cytology , Mesenchymal Stem Cells/cytology , 5'-Nucleotidase/analysis , Adipogenesis/physiology , Antigens, CD/analysis , Antigens, Surface/analysis , CD146 Antigen/analysis , Cell Adhesion/physiology , Cell Adhesion Molecules, Neuronal/analysis , Cell Aggregation/physiology , Cell Differentiation/physiology , Cell Shape , Chondrogenesis/physiology , Collagenases/administration & dosage , Connective Tissue Cells/cytology , Cytoskeleton/ultrastructure , Endoglin/analysis , Endopeptidases/administration & dosage , Fetal Proteins/analysis , Fibroblasts/cytology , GPI-Linked Proteins/analysis , Humans , Hyaluronan Receptors/analysis , Multipotent Stem Cells/cytology , Nerve Tissue Proteins/analysis , Osteogenesis/physiology , Receptors, Nerve Growth Factor/analysis , Stage-Specific Embryonic Antigens/analysis , Thy-1 Antigens/analysis , Time Factors , Vimentin/analysis
9.
Neuroscience ; 181: 109-16, 2011 May 05.
Article in English | MEDLINE | ID: mdl-21377513

ABSTRACT

We previously described a role for adrenergic signaling in the hippocampus to promote contextual and spatial memory retrieval. A subsequent study performing expression analysis of the immediate-early gene (IEG) Arc suggested that activation of CA1 but not CA3 pyramidal neurons during memory retrieval is impaired in the absence of NE. The current study sought to confirm and extend those observations by performing expression analysis of a second IEG product, Fos, following a much greater variety of testing conditions. In mutant mice lacking NE, induction of Fos was normal in all regions of the hippocampus and amygdala shortly after fear conditioning. In contrast, when testing contextual fear 1 day after training, induction of Fos in CA1 and the central nucleus of the amygdala (CeA), but not CA3, the dentate gyrus or other amygdaloid nuclei, was impaired in the mutant mice. This pattern corresponded to the memory retrieval deficit exhibited by these mice. On the other hand, induction was normal in CA1 and CeA when testing cued fear 1 day after training, or contextual fear 1 week or 1 month after training, conditions in which retrieval are normal in the absence of NE. Acute restoration of NE in the mutant mice before testing but not before training rescued retrieval of contextual fear and restored Fos induction in CA1 and CeA. Because NE facilitates retrieval through the activation of ß(1)-adrenergic receptors, ß(1) knockout mice were also examined and found to exhibit reduced induction of Fos in CA1 and CeA following retrieval. Based on these and previous results, we hypothesize that adrenergic signaling is critical for the full activation of CA1 pyramidal neurons in response to excitatory input from CA3 pyramidal neurons conveying retrieved contextual information.


Subject(s)
CA1 Region, Hippocampal/metabolism , Memory/physiology , Norepinephrine/deficiency , Pyramidal Cells/physiology , Receptors, Adrenergic, beta-1/deficiency , Signal Transduction/physiology , Amygdala/metabolism , Animals , Avoidance Learning/physiology , Biomarkers/analysis , Biomarkers/metabolism , CA3 Region, Hippocampal/physiology , Fear/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Neural Pathways/physiology , Norepinephrine/genetics , Norepinephrine/pharmacology , Proto-Oncogene Proteins c-fos/analysis , Proto-Oncogene Proteins c-fos/metabolism , Receptors, Adrenergic, beta-1/drug effects , Receptors, Adrenergic, beta-1/genetics
10.
Regul Pept ; 167(1): 50-5, 2011 Feb 25.
Article in English | MEDLINE | ID: mdl-21134405

ABSTRACT

Ghrelin is the endogenous ligand for the growth hormone secretagogue receptor (GHS-R). The sequence of ghrelin has been determined in many species ranging from fish to mammals. The ostrich is the largest herbivorous bird in the world. Although the distribution, morphological characteristics, and developmental changes of ghrelin-producing cells in the gastrointestinal tract of African ostrich chicks have recently been determined, the sequence and structure of ghrelin and its expression in the gastrointestinal tract of African ostrich chicks have not been studied. In the present study, the sequence and structure of ghrelin and its expression in the gastrointestinal tract of African ostrich chicks were investigated by reverse-transcriptase polymerase chain reaction (RT-PCR). Results of cDNA cloning revealed that African ostrich ghrelin is composed of 28 amino acid residues and the sequence of the 7 amino acids of the N-terminal region of African ostrich ghrelin was identical with that of other birds. Ninety-day-old female African ostriches were used to investigate the expression of ghrelin in the gastrointestinal tract. The results showed that ghrelin mRNA existed in the proventriculus, gizzard, duodenum, ileum, cecum, and rectum; there was no expression in the jejunum and colon. We observed developmental changes in the ghrelin mRNA expression in the stomach and small intestine of African ostriches. The results of the present study showed that ghrelin mRNA existed on day 1 in the proventriculus, but there was no expression in other tissues. On day 45, ghrelin mRNA existed in the proventriculus, gizzard, and ileum; however, there was no expression in the duodenum and jejunum. On day 90 and 334, we detected ghrelin mRNA in the proventriculus, gizzard, duodenum, and ileum, but there was no expression in the jejunum. The results of the present study clearly demonstrate that ghrelin mRNA exists and the distribution of ghrelin mRNA in the gastrointestinal tract of African ostriches changes with age (from postnatal day 1 to day 334).


Subject(s)
DNA, Complementary/genetics , DNA, Complementary/metabolism , Ghrelin/metabolism , Phylogeny , Recombinant Proteins/metabolism , Age Factors , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Escherichia coli , Female , Gastrointestinal Tract/physiology , Gene Expression , Gene Expression Regulation, Developmental , Ghrelin/genetics , Molecular Sequence Data , RNA, Messenger/biosynthesis , Receptors, Ghrelin/metabolism , Recombinant Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology , Stomach, Avian/physiology , Struthioniformes/genetics , Struthioniformes/metabolism
11.
J Hazard Mater ; 180(1-3): 354-60, 2010 Aug 15.
Article in English | MEDLINE | ID: mdl-20452724

ABSTRACT

This study presents a screening protocol to evaluate the applicability of the ZVI pretreatment to various industrial wastewaters of which major constituents are not identified. The screening protocol consisted of a sequential analysis of UV-vis spectrophotometry, high-performance liquid chromatograph (HPLC), and bioassay. The UV-vis and HPLC analyses represented the potential reductive transformation of unknown constituents in wastewater by the ZVI. The UV-vis and HPLC results were quantified using principal component analysis (PCA) and Euclidian distance (ED). The short-term bioassay was used to assess the increased biodegradability of wastewater constituents after ZVI treatment. The screening protocol was applied to seven different types of real industrial wastewaters. After identifying one wastewater as the best candidate for the ZVI treatment, the benefit of ZVI pretreatment was verified through continuous operation of an integrated iron-sequencing batch reactor (SBR) resulting in the increased organic removal efficiency compared to the control. The iron pretreatment was suggested as an economical option to modify some costly physico-chemical processes in the existing wastewater treatment facility. The screening protocol could be used as a robust strategy to estimate the applicability of ZVI pretreatment to a certain wastewater with unknown composition.


Subject(s)
Industrial Waste , Iron/chemistry , Biological Assay , Bioreactors , Chromatography, High Pressure Liquid , Principal Component Analysis , Spectrophotometry, Ultraviolet
12.
Hernia ; 14(5): 523-5, 2010 Oct.
Article in English | MEDLINE | ID: mdl-19894020

ABSTRACT

A 47-year-old female complained of abdominal pain in the epigastrium for about 2 h after a meal. At the initial abdominal radiograph, there were no findings of remarkable bowel loops. On the following day of hospitalization, the pain became worse; moreover, it could not be controlled by medicine. Also, a dilated bowel loop was detected on the imaging studies. When exploring the peritoneal cavity, we found a strangulated small bowel that protruded through the lesser omental sac within the defects of the gastrocolic or gastrohepatic ligaments. After performing manual reduction, the restoring viability of herniated small bowel failed; consequently, extensive small bowel resection was mandatory. Herein we reported a case of extensive small bowel hemorrhagic infarction due to a double omental hernia that was not diagnosed at the time of visiting the emergency department.


Subject(s)
Diagnostic Errors , Hernia/diagnosis , Infarction/diagnosis , Intestine, Small/blood supply , Laparotomy/methods , Omentum , Peritoneal Diseases/diagnosis , Diagnosis, Differential , Female , Follow-Up Studies , Hernia/complications , Herniorrhaphy , Humans , Infarction/etiology , Infarction/surgery , Middle Aged , Peritoneal Diseases/complications , Peritoneal Diseases/surgery , Radiography, Abdominal , Tomography, X-Ray Computed
13.
Eur Surg Res ; 42(4): 203-8, 2009.
Article in English | MEDLINE | ID: mdl-19270458

ABSTRACT

BACKGROUND/AIMS: The purpose of this study was to determine the effect of performing laparoscopic cholecystectomy on patients undergoing laparoscopic-assisted gastrectomy for gastric cancer. METHODS: This single center study involved a retrospective review of a database of 400 patients who underwent consecutive laparoscopic-assisted gastrectomy for early gastric cancer from June 2003 to July 2007. Outcomes in 26 patients who underwent both laparoscopic-assisted gastrectomy and laparoscopic cholecystectomy were compared with outcomes from 364 patients who underwent laparoscopic-assisted gastrectomy without laparoscopic cholecystectomy. RESULTS: There were no postoperative 30-day mortalities in the combined cholecystectomy group. The mean surgery duration, time to first flatus and postoperative hospital stay for the laparoscopic gastric resection without combined operation were 181.7 min, 2.7 days and 9.7 days, respectively, and 196.7 min, 2.6 days and 8.8 days, respectively, for the combined cholecystectomy group. None of the postoperative complications was related to combined cholecystectomy. CONCLUSION: Performing a combined cholecystectomy prolonged the mean surgery duration by approximately 15 min, but had no effect on surgical outcomes. It appears that performing a cholecystectomy at the same time as laparoscopic gastric resection is safe and feasible in patients with both early gastric cancer and gallbladder disease.


Subject(s)
Cholecystectomy, Laparoscopic/adverse effects , Gallbladder Diseases/surgery , Gastrectomy/adverse effects , Postoperative Complications/epidemiology , Stomach Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Eating , Female , Gallbladder Diseases/complications , Humans , Korea/epidemiology , Male , Middle Aged , Retrospective Studies , Stomach Neoplasms/complications , Stomach Neoplasms/mortality , Treatment Outcome , Young Adult
14.
Hum Reprod ; 23(9): 2086-94, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18343807

ABSTRACT

BACKGROUND: The HEL-75 protein is a beta-defensin that was identified by analyzing a human epididymis cDNA library. Studying its function may not only elucidate the mechanisms of host defense, but may also provide new alternatives for novel therapeutic drugs for reproductive tract infections. METHODS: The HEL-75 gene was amplified by PCR, and its structure and function were predicted and analyzed with bioinformatics tools. Polyclonal serum was raised against recombinant HEL (rHEL)-75 protein. The gene expression pattern was analyzed with RT-PCR and immunofluorescent staining. Finally, the antimicrobial activity and function during fertilization of HEL-75 were analyzed using a colony-forming unit assay and IVF, respectively. RESULTS: The human HEL-75 gene is located on chromosome 20p13 and encodes a 95 amino acid protein with a predicted N-terminal signal peptide of 22 amino acids. The protein has six conserved cysteine residues, characteristic of members of the beta-defensin superfamily, as well as several potential post-translational modification sites. At the transcriptional level, HEL-75 was expressed in the epididymis and lung, but only in the epididymis at the translational level. Immunofluorescent staining showed that HEL-75 protein bound spermatozoa in the epididymis. RHEL-75 protein could kill Escherichia coli in vitro in a dose- and time-dependent fashion. However, no effect was observed on sperm motility nor fertilization when spermatozoa were blocked with anti-rHEL-75 polyclonal serum. CONCLUSION: HEL-75 is a new beta-defensin expressed in the epididymis and on sperm; it may play an important role in host defense.


Subject(s)
Epididymis/metabolism , Seminal Plasma Proteins/physiology , Spermatozoa/metabolism , beta-Defensins/physiology , Amino Acid Sequence , Anti-Bacterial Agents/metabolism , Anti-Bacterial Agents/pharmacology , Base Sequence , Cloning, Molecular , DNA, Complementary/chemistry , Embryonic Development , Escherichia coli/drug effects , Humans , Lung/metabolism , Male , Microbial Sensitivity Tests , Molecular Sequence Data , RNA, Messenger/metabolism , Recombinant Fusion Proteins/analysis , Seminal Plasma Proteins/chemistry , Seminal Plasma Proteins/pharmacology , Sperm Motility , beta-Defensins/chemistry , beta-Defensins/pharmacology
15.
Transplant Proc ; 38(7): 2025-8, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16979988

ABSTRACT

Basiliximab is widely used in clinical practice for initial immunosuppressive treatment of renal transplant recipients, seeking to reduce the incidence of acute rejection episodes without adverse events. This retrospective study included 123 renal allograft recipients transplanted at a single center. All were followed for longer than 1 year after transplantation and treated with calcineurin inhibitor and steroid (methylprednisolone) for prophylactic immunosuppression, but basiliximab and mycophenolate mofetil were optional. We compared the outcomes of renal transplant recipients who were versus treated were not with basiliximab as initial immunosuppressive therapy. Basiliximab was used for initial immunosuppression in 42 patients. Their maintenance immunosuppressive treatment included triple (n = 44) or double (n = 79) regimens, including a calcineurin inhibitor (cyclosporine [n = 87] or tacrolimus [n = 36]), methylprednisolone with or without mycophenolate mofetil. Twenty-six (21.1%) patients had a rejection episode within 1 year after transplantation and 22 (17.9%) had infections. Within the first year after transplantation the patients who were treated with basiliximab showed fewer rejection episodes (n = 6, 14.3%) than the patients without this therapy (n = 20, 24.7%), which was not statistically significant (P = .245). However, basiliximab significantly affected the occurrence of rejection episodes among the double immunosuppressive regimen group (P = .006), but not the triple regimen group (P = .098) without an impact on infection episodes (P value of double, triple = .291, .414) within 1 year after transplantation. We concluded that basiliximab was more useful for the recipients treated with double immunosuppression with a calcineurin inhibitor and steroid than for those on a triple regimen including mycophenolate mofetil.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/immunology , Recombinant Fusion Proteins/therapeutic use , Adult , Basiliximab , Cyclosporine/therapeutic use , Drug Therapy, Combination , Female , Graft Rejection/prevention & control , Histocompatibility Testing , Humans , Living Donors , Male , Middle Aged , Retrospective Studies , Tissue Donors , Treatment Outcome
16.
Neuroscience ; 133(3): 647-55, 2005.
Article in English | MEDLINE | ID: mdl-15893884

ABSTRACT

Analysis of mice with targeted disruptions of fosB or the gene encoding dopamine beta-hydroxylase suggests that FosB and adrenergic signaling play critical roles in maternal nurturing behavior. The majority of neonates born to null females from either mutation fail to thrive, and virgin mutant females of both lines exhibit impaired pup retrieval. Considering whether FosB and adrenergic signaling might share a signaling pathway important for maternal behavior, we examined the role of a potential intermediary, cyclic AMP response element-binding protein (CREB). Here we report that approximately 40% of neonates (all heterozygous) born to mice lacking the major isoforms of CREB (Creb-alphaDelta-/-) died within several days of birth. In contrast, heterozygotes born to Creb-alphaDelta+/- females thrived. Cross-fostering demonstrated that neonates born to Creb-alphaDelta(-/dagger/-) females thrived when reared by wild-type females, and that Creb-alphaDelta-/- females were capable of rearing neonates whose maternal care was initiated by wild-type females. Further, virgin Creb-alphaDelta-/- females were deficient in pup retrieval despite exhibiting normal investigation of pups and of novel objects. No maternal behavior phenotype was present in mice with a null mutation of the cyclic AMP response element modulator (Crem) gene. Interestingly, the number of cells immunostaining for phospho-CREB (on Ser(133)) in the medial preoptic area of the hypothalamus, a key region for the expression of maternal behavior, increased nearly three-fold in wild-type mice following exposure to pups but not to novel objects. On the other hand, basal expression and induction of FosB in response to pup exposure appeared to be independent of CREB because levels were equivalent between wild-type and Creb-alphaDelta-/- females. These results implicate CREB in maternal nurturing behavior and suggest that CREB is not critical for expression or induction of FosB in adult virgin female mice.


Subject(s)
Behavior, Animal/physiology , Cyclic AMP Response Element-Binding Protein/genetics , Maternal Behavior/physiology , Preoptic Area/physiology , Animals , Animals, Newborn , Cyclic AMP Response Element Modulator , DNA-Binding Proteins/genetics , Exploratory Behavior/physiology , Female , Genotype , Male , Mice , Mice, Mutant Strains , Phosphorylation , Pregnancy , Proto-Oncogene Proteins c-fos/genetics , Survival Rate , Transcription Factors/genetics
17.
Int J Audiol ; 43 Suppl 1: S22-7, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15732378

ABSTRACT

The primary goal of this study was to compare the characteristics of the post-implant evoked potentials with preimplant evoked potentials in patients with auditory neuropathy (AN) or dys-synchrony. AN is typically characterized by sensorineural hearing loss, reduced speech perception, abnormal temporal processing, and unusual patterns of results with various objective audiological tests. In some cases, these patients may be appropriate candidates for a cochlear implant. In this article, we highlight evoked potential findings in two children diagnosed with AN who were provided with multichannel cochlear implants. Preoperative, interoperative and postoperative evoked potential measures show that the restoration of neural synchrony may occur at multiple levels of the auditory pathways in patients with AN when appropriate diagnostic tests, cochlear implantation and rehabilitation are provided.


Subject(s)
Auditory Diseases, Central/physiopathology , Cochlear Implants , Evoked Potentials, Auditory , Hearing Loss, Sensorineural/physiopathology , Acoustic Impedance Tests , Audiometry, Pure-Tone , Child, Preschool , Female , Follow-Up Studies , Hearing Loss, Sensorineural/therapy , Humans , Infant , Male , Otoacoustic Emissions, Spontaneous
18.
J Pharmacol Exp Ther ; 298(2): 651-7, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11454927

ABSTRACT

Norepinephrine (NE) is thought to play an important role in the pathophysiology of depression, and in the mechanism of action of antidepressant compounds. Previously, we created mice that are unable to synthesize NE and epinephrine due to targeted disruption of the dopamine-beta-hydroxylase gene (Dbh). To specifically test the role of NE in mediating behavioral changes elicited by antidepressants, these mice were examined in the forced swim test. There was no difference in baseline immobility scores in the forced swim test between Dbh(+/-) mice, which have normal levels of NE, and Dbh(-/-) mice. However, the Dbh(-/-) mice failed to demonstrate antidepressant-like behavioral effects following the administration of several classes of antidepressants. These included the NE reuptake inhibitors desipramine and reboxetine, the monoamine oxidase inhibitor pargyline, and the atypical antidepressant bupropion. In addition, desipramine significantly reduced immobility in the Dbh(-/-) mice following pretreatment with the synthetic NE precursor L-threo-3,4-dihydroxyphenylserine, but not saline. Biochemical studies showed that there was no significant difference in the regional brain levels of NE transporter immunoreactivity or monoamine oxidase activity, the primary targets for most of the compounds examined. Taken together, these data show that the use of mice that lack endogenous NE may be an important strategy for unraveling the role of NE in tests sensitive to the effects of various psychotherapeutic agents.


Subject(s)
Antidepressive Agents/pharmacology , Depression/psychology , Dopamine beta-Hydroxylase/deficiency , Norepinephrine/physiology , Animals , Antidepressive Agents, Second-Generation/pharmacology , Antidepressive Agents, Tricyclic/pharmacology , Behavior, Animal/drug effects , Depression/drug therapy , Depression/genetics , Dopamine beta-Hydroxylase/genetics , Mice , Mice, Knockout , Monoamine Oxidase/metabolism , Monoamine Oxidase Inhibitors/pharmacology , Signal Transduction/physiology , Swimming/psychology
19.
Int J Colorectal Dis ; 16(3): 167-73, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11459290

ABSTRACT

The mechanisms of the antineoplastic effect of nonsteroidal anti-inflammatory drugs (NSAIDs) still are unknown, but the induction of apoptosis is one of the possible mechanisms. We attempted to demonstrate the role of mitogen-activated protein (MAP) kinases, generally considered to be important mediators of proliferative and apoptotic signals, in NSAID-induced colon cancer cell apoptosis. Apoptosis was detected by demonstration of DNA fragmentation in agarose gel electrophoresis. Cell death was assessed by trypan blue dye exclusion method. MAP kinase activation was assessed by Western blot using phosphospecific antibodies to MAP kinases. Kinase assay using activating transcription factor-2 (ATF-2) fusion protein as a substrate was also performed for measuring p38 MAP kinase activity. For the inhibition of p38 MAP kinase, pyridinylimidazole compound (SB203580) was utilized. Caspase-3 activity was measured using the tetrapeptide fluorogenic substrate Ac-DEVD-AMC. Treatment of HT-29 cells with NSAIDs results in time- and dose-dependent induction of apoptosis, accompanied by sustained activation of all three MAP kinase subfamilies. The SB203580, a p38 MAP kinase inhibitor, reduced indomethacin-induced cell death by 43%, while PD098059, a MAPK/ERK kinase (MEK)1 inhibitor, did not affect cell death. p38 MAP kinase and caspase-3 activation were not significantly interlinked in indomethacin-induced apoptosis. From these results, we conclude that NSAIDs can induce prolonged activation of MAP kinases in colon cancer cells and that, of these, p38 MAP kinase may play a partial but significant role in indomethacin-induced apoptosis.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Apoptosis/drug effects , Butanones/pharmacology , HT29 Cells/drug effects , Indomethacin/pharmacology , Mitogen-Activated Protein Kinases/drug effects , Sulindac/pharmacology , Blotting, Western/methods , Enzyme Activation/drug effects , HT29 Cells/enzymology , Humans , JNK Mitogen-Activated Protein Kinases , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/metabolism , Nabumetone , p38 Mitogen-Activated Protein Kinases
20.
Arch Pharm Res ; 23(5): 518-24, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11059834

ABSTRACT

We examined the modulation of protein kinase C (PKC) subtypes during apoptosis induced by ginsenoside Rh2 (G-Rh2) in human neuroblastoma SK-N-BE(2) and rat glioma C6Bu-1 cells. Apoptosis induced by G-Rh2 in both cell lines was confirmed, as indicated by DNA fragmentation and in situ strand breaks, and characteristic morphological changes. During apoptosis induced by G-Rh2 in SK-N-BE(2) cells, PKC subtypes alpha, beta and gamma were progressively increased with prolonged treatment, whereas PKC delta increased transiently at 3 and 6 h and PKC epsilon was gradually down-regulated after 6 h following the treatment. On the other hand, PKC subtype zeta markedly increased at 24 h when maximal apoptosis was achieved. In C6Bu-1 cells, no significant changes in PKC subtypes alpha, gamma, delta, epsilon and zeta were observed during apoptosis induced by G-Rh2. These results suggest the evidence for a possible role of PKC subtype in apoptosis induced by G-Rh2 in SK-N-BE(2) cells but not in C6Bu-1 cells, and raise the possibility that G-Rh2 may induce apoptosis via different pathways interacting with or without PKC in different cell types.


Subject(s)
Apoptosis/drug effects , Drugs, Chinese Herbal/pharmacology , Ginsenosides , Isoenzymes/physiology , Protein Kinase C/physiology , Saponins/pharmacology , Animals , Humans , Rats , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...